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recently four weeks. All the patients provided detailed information of
history of illness, received carefully physical and laboratory exami-
nations and were performed ambulatory blood pressure monitoring
(ABPM) and ambulatory electrocardiogram (ECG) recording mean-
while. We collected carotid ultrasonography, brachial-to-ankle pulse
wave velocity (ba–PWV) and ankle brachial index (ABI) from most
of these patients. All patients were divided into the MBPS group,
which was deﬁned as having the highest quartile of morning BP
increase from sleep (28.67mmHg; n ¼ 44) and the non-MBPS
group(<28.67mmHg; n ¼ 116). And then we compared all indexes
between these two groups.
RESULTS MBPS was correlated positively with day–night systolic
blood pressure (SBP) dipping (r ¼ 0.5, p<0.001).And the circadian
blood pressure pattern was mostly dipper in MBPS group, while non-
dipper in non–MBPS group. Compared with patients in non–MBPS
group, those in MBPS group had higher 24 hours systolic blood pres-
sure variability (24h–SBP–BPV), 24 hours diastolic blood pressure
variability (24h–DBP–BPV), nighttime systolic blood pressure vari-
ability (N–SBP–BPV) and nighttime diastolic variability (N–DBP–BPV).
And their correlation coefﬁcients with MBPS were 0.325,0.315,0.316
and 0.286 respectively (p <0.001). After adjustments for factors
associated with MBPS these correlations still existed signiﬁcantly,
except for N–DBP–BPV. The morning heart rate surge (MHRS), the
24 hours mean systolic blood pressure (24 h–SBP) proﬁle and daytime
mean diastolic blood pressure (D–SBP) proﬁle were higher in the MBPS
group than in the non–MBPS group (MHRS: 15.81  6.86 bpm versus
13.22  7.11 bpm, p<0.05; 24h–SBP: 136.41  16.32 mmHg versus 130.41
 15.93 mmHg, p<0.05; D–SBP:140.52  16.44 mmHg versus 131.76 
17.34 mmHg, p <0.05 ) and they all had no linear correlations with
MBPS.
CONCLUSIONS In young and middle-aged essential hypertensive
patients, the day-night SBP dipping, 24h–BPV and N–BPV may be
important factors associated with MBPS. Compared with DBP–BPV,
SBP–BPV has greater inﬂuence on MBPS. 24h–BPV also has more in-
ﬂuence on MBPS than N–BPV. Meanwhile, we also ﬁnd that MHRS is
related to MBPS. Therefore, we speculate that in these young and
middle–aged essential hypertensive patients, sympathetic nervous
system activation may be the main mechanism underlying MBPS.
Moreover, 24h–SBP and D–SBP also have an effect on MBPS to some
extent.GW26-e2487
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OBJECTIVES To evaluate the clinical characteristics of primary aldo-
steronism (PA) with hypertension.
METHODS From 2002 to 2015, 56 patients with PA were diagnosed
according 2008 American endocrine society clinical practice guideline
about PA. Clinical proﬁles and fasting serum sodium, potassium,
aldosterone level, plasma rennin activity, angiotensin level, aldoste-
rone-to-rennin activity ratio(ARR), cystatin C(CysC) and b2-micro-
globulin (b2-M) were recorded and analyzed.
RESULTS Of these patients, age of diagnosis was (48.912.4) years,
62.5% were male, 69.6% were aldosteronoma, 30.4% were idiopathic
aldosteronism. Course of hypertension was (5.365.24) years, in
which 27.8% were less than 1 year, 33.3% were 1-5 years, 29.6% were 5-
10 years, 9.3% were over 10 years. The prevalence of 1, 2, and 3 stage
hypertension in these patients was 61.1%, 29.6%, and 9.3%, respec-
tively. It was found that systolic blood pressure (166.520.4) mmHg,
diastolic blood pressure (94.316.7) mmHg, PRA(0.300.29) ng/ml/h,
aldosterone level(26.117.3) ng/dl, angiotensin II level (115.5103.9)
pg/ml, ARR (107.17(45.28, 560.17)). The incidence of hypokalemia,
hypernatremia and arteriosclerosis was 64.8%, 20.4%, 39.3%,
respectively. Correlation analysis showed that the course of PA was
positively correlated with CysC, b2-M, serum sodium (r¼0.348,
r¼0.453, r¼0.401, P<0.05), negatively correlated with serum potas-
sium (r¼ - 0.277, P<0.05). It was also shown that diastolic blood
pressure was positively correlated with aldosterone level (r¼ 0.282,
P<0.05).
CONCLUSIONS Primary aldosteronism with hypertension was more
likely to happen in middle-aged men due to aldosteronoma,manifested as mild to moderate hypertension, with relatively long
course before diagnosis which may affect several related factors.
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OBJECTIVES To investigate the association between plasmic Brain
Natriuretic Peptide (BNP) and essential hypertension (EH) Target-
organ Damage (TOD).
METHODS We studied 83 never-treated patients with essential
hypertension and 20 normal subjects. Hypertensive patients were
divided into two groups. one group was 68 patients with target-organ
damage and the other was 15 patients without target-organ dam-
age(pure hypertensive patients). Then 68 patients with TOD were
subdivide into subgroups: with 30 left ventricular hypertrophy(LVH),
10 carotid artery wall thickening, 10 renal damage and 18 stroke. All
subjects received general situation, blood pressure, fasting plasma
glucose and blood lipid levels, liver function, renal function, urinary
albumin, a standard 12-lead ECG, 24-hour blood pressure, echocardi-
ography, carotid ultrasonography and cerebral CT or MRI so on. The
plasmic BNP quantity were measured by Enzyme-linked immuno-
sorbent assay(ELISA).
RESULTS 1.The plasma level of BNP was elevated in the essential
hypertension(EH) group than normal subjects(P<0.05). 2.essential
hypertension with target organ damage in each subgroup of plasma
BNP levels were higher than in pure essential hypertension group and
normal control group, the differences were statistically signiﬁcant
(P<0.05). And the plasma BNP level comparison among various sub-
groups of essential hypertension with target organ damage, there
were no statistically signiﬁcant difference (P>0.05). 3.In patients with
LVH correlation analysis showed that: The plasma level of BNP took
positive correlation with left ventricular mass index(LVMI) (r¼0.693,
P<0.01), took inverse correlation with LVEF(r¼-0.768, P<0.01).
CONCLUSIONS These results indicate that BNP is related to the oc-
currences and developments of essential hypertension and target-
organ damage, may become a no-traumatic laboratory indicator in the
process of essential hypertension diagnosis and treatment. It has a
positive meaning in the disease of changes and prognosis assessment
to guide clinical treatment through measuring BNP levels in patients
with hypertension and target-organ damage.
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OBJECTIVES Although the effects of statins on blood pressure has
been conﬁrmed, the efﬁcacy of different dose atorvastatin on blood
pressure remains controversial. Our meta-analysis was performed of
different dose atorvastatin on blood pressure in humans including the
randomized, controlled trials of atorvastatin therapy.
METHODS We collected data from twenty-seven randomized control
trials of atorvastatin that had the blood pressure reported as one of
the endpoints. Weighted Mean Difference(WMD) was used as a mea-
sure of the effect of atorvastatin on blood pressure.The analysis was
further stratiﬁed by factors that could affect the treatment effect.
RESULTS We found that systolic blood pressure (SBP) in the ator-
vastatin group decreased by 3.14 mmHg (95% conﬁdence interval
[CI]:2.13 to 4.15 mmHg) and diastolic blood pressure (DBP) by
1.35 mmHg (95% CI: 0.78 to 1.92 mmHg). In 10mg atorvastatin groups,
SBP decreased by 1.17 mmHg (95% CI: 0.22 to 2.13 mmHg), but DBP had
no change (DBP: 0.17 mmHg; 95% CI:-0.64 to 0.98 mmHg). In 20mg
atorvastatin groups, SBP decreased by 5.82 mmHg (95% CI: 2.32 to
9.32 mmHg) and DBP by 2.93 mmHg (95% CI: 1.11 to 4.75 mmHg). In
40mg atorvastatin groups, SBP decreased by 3.58 mmHg (95% CI: 0.10
to 7.06 mmHg) and DBP by 2.76 mmHg (95% CI: 0.38 to 5.14 mmHg). In
80mg atorvastatin groups, SBP decreased by 2.98 mmHg (95% CI: 2.12
to 3.84 mmHg), but DBP had no changes (DBP: 0.24 mmHg, 95% CI:
-2.72 to 3.20 mmHg).
CONCLUSIONS Our ﬁndings indicated that different dose atorvasta-
tin therapy has a relatively small but statistically signiﬁcant and
clinically meaningful effect on blood pressure.
